Explore articles tagged with US Tariffs
HRV Pharma CEO Hari Kiran Chereddi explains why drug development success is now determined before manufacturing, driven by data, predictive analytics, and strategic decision-making.
HRV Pharma CEO Hari Kiran Chereddi shares insights on how platform-driven models are transforming pharma from factory-led systems to intelligent, network-based ecosystems.
Our leadership analyzes impact of US 50% tariffs on Indian pharmaceutical exports, highlighting challenges for SMEs and strategic responses including market diversification.